Activities of Iva ZANICCHI related to 2012/2135(INI)
Shadow reports (1)
REPORT on development aspects of intellectual property rights on genetic resources: the impact on poverty reduction in developing countries PDF (236 KB) DOC (145 KB)
Amendments (10)
Amendment 2 #
Motion for a resolution
Citation 16 a (new)
Citation 16 a (new)
- having regard to the 1971 Ramsar convention on Wetlands;
Amendment 3 #
Motion for a resolution
Citation 16 b (new)
Citation 16 b (new)
- having regard to the 1973 CITES convention on trade of endangered species
Amendment 15 #
Motion for a resolution
Paragraph 1
Paragraph 1
1. Recalls the direct link between the protection of biodiversity and the achievement of the MDGs;, in particular MDG1 focused on the eradication of extreme poverty and hunger: stresses the importance of healthy biodiversity and ecosystems for agriculture, forestry and fisheries within a sustainable development perspective;
Amendment 19 #
Motion for a resolution
Paragraph 3
Paragraph 3
3. Underlines the fact that, although there is no general definition of the term ‘biopiracy’, it usually refers to the pre- industrial practice of privatising and patenting products based onand industrial misappropiation and malpractice of benefiting commercially from the traditional knowledge or genetic resources of indigenous peoples, without authorisation or providing compensation to source countries;
Amendment 29 #
Motion for a resolution
Paragraph 9
Paragraph 9
9. Notes that traditional knowledge designates knowledge possessed by specific indigenous and local communities and shared by many segments of the society of a particular region or country; Points out that traditional knowledge includes "intangible values"; the maintenance of cultural heritage, indeed, is of primary importance in all its expressions: social, religious, cultural and landscape values;
Amendment 30 #
Motion for a resolution
Paragraph 10
Paragraph 10
10. Points out that three quarters of the plants used in modern medicine come from traditional medicine; bBelieves that biopiracy means there is a strong case for protecting traditional knowledge, particularly when it is associated with genetic resources of economic value to the pharmaceuticals industindustrial sector. Notes that industry research utilizing natural products has been in sharp decline for many years as it has been supersede by more advanced approaches to discovery;
Amendment 46 #
Motion for a resolution
Paragraph 17
Paragraph 17
17. BelievNotes that a binding instrument is the surest way to see biodiversity-related measures in the absence of clear evidence regarding the IPR system implemented by user countries; urges that steps be taken to make the granting of patents dependent on compliance with a mandatory requirement to disclose the origin of any GR/TK in patent applications; stresses that such disclosure should include proof that the GR/TK in question has been acquired in accordance with applicable rules (i.e. prior informed consent and mutually agreed terms)current nature and extent of biopiracy, and given that the Nagoya Protocol will have prospective effect, it would be premature to regulate this sector with a binding instrument;
Amendment 49 #
Motion for a resolution
Paragraph 18
Paragraph 18
18. Notes with concern that, while the CBD aims at fair and equitable access and benefit sharing between providers and users of genetic resources, for 20 years WTO-TRIPS has favoured users of genetic resources through the WTO dispute-settlement mechanism for patent protectionPoints out that the evidence of over a decade of deliberation in the multilateral organizations suggests that the patent system is an unsatisfactory regulatory tool for addressing acts of misappropriation; notes that it is widely-accepted that the most effective means of achieving the goals of the CBD is through the development of equitable contracts between source countries and recipients, supported by sectoral arrangements and codes of conduct and that patents may be an important mean of generating value for source countries and their indigenous communities;
Amendment 52 #
Motion for a resolution
Paragraph 19
Paragraph 19
19. Insists that WTO-TRIPS should be compatible with the CBD-Nagoya Protocol, and therefore considers it crucial to establish mandatoryeffective access and benefit- sharing requirements oin disclosing the origin of genetic resources during patent proceedingnational or regional legislation based on mutually agreed terms, including terms relating to intellectual property, to achieve the CBD's objectives;
Amendment 54 #
Motion for a resolution
Paragraph 20
Paragraph 20
20. Stresses that such requirements could be introduced via an amendment of the WTO-TRIPS Agreement or under WIPO; likewise takes the view that the EU should establish a clear mandatory requirement to disclose the orin effective access and benefit- sharing regime for the European region of any genetic resources and associated traditional knowledge in patent applications in EU legislation in the absence of an international agreementbased on mutually agreed terms, including terms relating to intellectual property, to achieve the CBD's objectives;